U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07836478) titled 'Neurocognitive Integrity After Proton Therapy for Brain Tumor' on Sept. 14.
Brief Summary: Radiation therapy remains a cornerstone in the management of both benign and malignant intracranial tumors, either as monotherapy or combined with surgery and/or chemotherapy. Despite its therapeutic benefits, it is frequently associated with potential long-term adverse effects, with neurotoxicity posing a major challenge, especially in young patients affected by benign primary tumors.
Study Start Date: Sept., 2026
Study Type: OBSERVATIONAL
Condition:
Central Nervous System Tumour
Recruitment Status: NOT_YET_RECRUITING
Sponsor: European...